SpringerLink
Log in

Map** of Lymph Node Metastasis and Efficacy Index in Thoracic Esophageal Squamous Cell Carcinoma: A Large-Scale Retrospective Analysis

  • Thoracic Oncology
  • Published:
Annals of Surgical Oncology Aims and scope Submit manuscript

Abstract

Background

Esophageal squamous cell carcinoma has a high mortality rate in China. The metastatic pattern in the lymph nodes and the value of their dissection on the overall survival of these patients remain controversial. The primary aim of this study was to provide a basis for accurate staging of esophageal cancer and to identify the relationship between esophageal cancer surgery, lymph node dissection, and overall survival rates.

Methods

We utilized our hospital database to retrospectively review the data of 1727 patients with esophageal cancer who underwent R0 esophagectomy from January 2010 to December 2017. The lymph nodes were defined according to Japanese Classification of Esophageal Cancer, 11th Edition. The Efficacy Index (EI) was calculated by multiplying the frequency (%) of metastases to a zone and the 5-year survival rate (%) of patients with metastases to that zone, and then dividing by 100.

Results

The EI was high in the supraclavicular and mediastinal zones in patients with upper esophageal tumors, and the EI of 101R was 17.39, which was the highest among the lymph node stations. In patients with middle esophageal tumors, the EI was highest in the mediastinal zone, followed by the celiac and supraclavicular zones. Furthermore, the EI was highest in the celiac zone, followed by the mediastinal zones in patients with lower esophageal tumors.

Conclusions

The EI of resected lymph nodes was found to vary between stations and was related to the primary location of the tumor.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Global burden of disease. 2019 Cancer Collaboration, Kocarnik JM, Compton K, Dean FE, Fu W, Gaw BL, Harvey JD et al. Cancer incidence, mortality, years of life lost, years lived with disability, and disability-adjusted life years for 29 cancer groups from 2010 to 2019: A systematic analysis for the global burden of disease study. JAMA Oncol 2022;8(3):420-444

  2. Chen W, Zheng R, Baade PD, et al. Cancer statistics in China, 2015. CA Cancer J Clin. 2016;66(2):115-132. doi:https://doi.org/10.3322/caac.21338.

    Article  PubMed  Google Scholar 

  3. Liang H, Fan JH, Qiao YL. Epidemiology, etiology, and prevention of esophageal squamous cell carcinoma in China. Cancer Biol Med. 2017;14(1):33-41. doi:https://doi.org/10.20892/j.issn.2095-3941.2016.0093.

    Article  PubMed  PubMed Central  Google Scholar 

  4. Li C, Zhao S, Zheng Y, et al. Preoperative pembrolizumab combined with chemoradiotherapy for oesophageal squamous cell carcinoma (PALACE-1). Eur J Cancer. 2021;144:232-241. doi:https://doi.org/10.1016/j.ejca.2020.11.039.

    Article  CAS  PubMed  Google Scholar 

  5. Yang H, Liu H, Chen Y, et al. Neoadjuvant chemoradiotherapy followed by surgery versus surgery alone for locally advanced squamous cell carcinoma of the esophagus (NEOCRTEC5010): A phase III multicenter, randomized, open-label clinical trial. J Clin Oncol. 2018;36(27):2796-2803. doi:https://doi.org/10.1200/JCO.2018.79.1483.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  6. Ando N, Kato H, Igaki H, et al. A randomized trial comparing postoperative adjuvant chemotherapy with cisplatin and 5-fluorouracil versus preoperative chemotherapy for localized advanced squamous cell carcinoma of the thoracic esophagus (JCOG9907). Ann Surg Oncol. 2012;19(1):68-74. doi:https://doi.org/10.1245/s10434-011-2049-9.

    Article  PubMed  Google Scholar 

  7. Koenig AM, Prenzel KL, Bogoevski D, et al. Strong impact of micrometastatic tumor cell load in patients with esophageal carcinoma. Ann Surg Oncol. 2009;16(2):454-462. doi:https://doi.org/10.1245/s10434-008-0169-7.

    Article  PubMed  Google Scholar 

  8. Stein HJ, Feith M, Bruecher BL, Naehrig J, Sarbia M, Siewert JR. Early esophageal cancer: pattern of lymphatic spread and prognostic factors for long-term survival after surgical resection. Ann Surg. 2005;242(4):566-73; discussion 573. doi:https://doi.org/10.1097/01.sla.0000184211.75970.85.

    Article  PubMed  PubMed Central  Google Scholar 

  9. Castoro C, Scarpa M, Cagol M, et al. Nodal metastasis from locally advanced esophageal cancer: how neoadjuvant therapy modifies their frequency and distribution. Ann Surg Oncol. 2011;18(13):3743-3754. doi:https://doi.org/10.1245/s10434-011-1753-9.

    Article  PubMed  Google Scholar 

  10. Ajani JA, D’Amico TA, Bentrem DJ, et al. Esophageal and Esophagogastric Junction Cancers. version 2.2019, NCCN clinical practice guidelines in oncology. J Natl Compr Canc Netw; 2019;17:855-883.

    Article  CAS  PubMed  Google Scholar 

  11. Altorki NK, Zhou XK, Stiles B, et al. Total number of resected lymph nodes predicts survival in esophageal cancer. Ann Surg. 2008;248(2):221-226. doi:https://doi.org/10.1097/SLA.0b013e31817bbe59.

    Article  PubMed  Google Scholar 

  12. Wang Q, Peng L, Li T, et al. Postoperative chemotherapy for thoracic pathological T3N0M0 esophageal squamous cell carcinoma. Ann Surg Oncol. 2020;27(5):1488-1495. doi:https://doi.org/10.1245/s10434-019-08112-1.

    Article  PubMed  Google Scholar 

  13. Amin MB, Greene FL, Edge SB et al. 2017 The Eighth Edition AJCC cancer staging manual continuing to build a bridge from a population-based to a more personalized approach to cancer staging. CA Cancer J Clin 67: 93-99

  14. Japan Esophageal Society. Japanese Classification of Esophageal Cancer. 11th ed. Part I. Esophagus; 2017;14:1-36.

  15. Greenstein AJ, Litle VR, Swanson SJ, Divino CM, Packer S, Wisnivesky JP. Effect of the number of lymph nodes sampled on postoperative survival of lymph node-negative esophageal cancer. Cancer. 2008;112(6):1239-1246. doi:https://doi.org/10.1002/cncr.23309.

    Article  PubMed  Google Scholar 

  16. Sasako M, McCulloch P, Kinoshita T, Maruyama K. New method to evaluate the therapeutic value of lymph node dissection for gastric cancer. Br J Surg. 1995;82(3):346-351. doi:https://doi.org/10.1002/bjs.1800820321.

    Article  CAS  PubMed  Google Scholar 

  17. Tachimori Y, Ozawa S, Numasaki H, et al. Efficacy of lymph node dissection by node zones according to tumor location for esophageal squamous cell carcinoma. Esophagus. 2016;13:1-7. doi:https://doi.org/10.1007/s10388-015-0515-3.

    Article  PubMed  Google Scholar 

  18. Gertler R, Stein HJ, Schuster T, Rondak IC, Höfler H, Feith M. Prevalence and topography of lymph node metastases in early esophageal and gastric cancer. Ann Surg. 2014;259(1):96-101. doi:https://doi.org/10.1097/SLA.0000000000000239.

    Article  PubMed  Google Scholar 

  19. Kurokawa Y, Takeuchi H, Doki Y, et al. Map** of lymph node metastasis from esophagogastric junction tumors: A prospective nationwide multicenter study. Ann Surg. 2021;274(1):120-127. doi:https://doi.org/10.1097/SLA.0000000000003499.

    Article  PubMed  Google Scholar 

  20. Yang Y, Li Y, Qin J, et al. Map** of lymph node metastasis from thoracic esophageal cancer: A retrospective study. Ann Surg Oncol. 2022;29(9):5681-5688. doi:https://doi.org/10.1245/s10434-022-11867-9.

    Article  PubMed  Google Scholar 

  21. Wang FH, Zhang XT, Li YF, et al. The Chinese Society of Clinical Oncology (CSCO): clinical guidelines for the diagnosis and treatment of gastric cancer, 2021. Cancer Commun (Lond). 2021;41(8):747-795. doi:https://doi.org/10.1002/cac2.12193.

    Article  PubMed  Google Scholar 

  22. Wang Y, Zhang X, Zhang X, et al. Prognostic value of the extent of lymphadenectomy for esophageal cancer-specific survival among T1 patients. BMC Cancer. 2021;21(1):403. doi:https://doi.org/10.1186/s12885-021-08080-4.

    Article  PubMed  PubMed Central  Google Scholar 

  23. Rizk NP, Ishwaran H, Rice TW, et al. Optimum lymphadenectomy for esophageal cancer. Ann Surg. 2010;251(1):46-50. doi:https://doi.org/10.1097/SLA.0b013e3181b2f6ee.

    Article  PubMed  Google Scholar 

  24. Xu L, Wei XF, Chen XK, et al. Clinical significance of left tracheobronchial lymph node dissection in thoracic esophageal squamous cell carcinoma. J Thorac Cardiovasc Surg. 2022;164(4):1210-1219.e3. doi:https://doi.org/10.1016/j.jtcvs.2022.02.050.

    Article  PubMed  Google Scholar 

  25. Shang QX, Wang YC, Yang YS, Hu WP, Chen LQ. Pattern of subcarinal lymph node metastasis and dissection strategy for thoracic esophageal cancer. J Thorac Dis. 2020;12(10):5667-5677. doi:https://doi.org/10.21037/jtd-20-1776.

    Article  PubMed  PubMed Central  Google Scholar 

  26. Hu Y, Hu C, Zhang H, ** Y, Chen LQ. How does the number of resected lymph nodes influence TNM staging and prognosis for esophageal carcinoma? Ann Surg Oncol. 2010;17(3):784-790. doi:https://doi.org/10.1245/s10434-009-0818-5.

    Article  PubMed  Google Scholar 

Download references

Acknowledgment

Special thanks to Qifeng Wang (The Science and Technology Department of Sichuan Province (2023YFS0488 and 2023YFQ0055) for financial support, Reeyan Jiang for the creating Fig. 2 and everyone who has contributed to the database.

Funding

This work was supported by grants from the National Key Research and Development Program (2022YFC2403400), International Cooperation Projects of Science and Technology Department of Sichuan Province (Grant No. 2020YFH0169), the Sichuan Key Research and Development Project from Science and Technology Department of Sichuan Province (Grant No. 2023YFS0044, 2023YFQ0056, No. 2021YJ0118), the Wu Jie** Clinical Research Projects (Grant No. 320.6750.2020-15-3), and Sichuan Province Clinical Key Specialty Construction Project.

Author information

Authors and Affiliations

  1. Division of Thoracic Surgery, Sichuan Cancer Research Center for Cancer, Sichuan Cancer Hospital and Institute, Sichuan Cancer Center, Affiliated Cancer Hospital of University of Electronic Science and Technology of China, Chengdu, Sichuan, People’s Republic of China

    Kexun Li MD, **n Nie MD, Changding Li MD, Wenwu He MD, PhD, Chenghao Wang MD, PhD, Kunyi Du MD, Kunzhi Li MD, Kun Liu MD, Zhiyu Li MD, Simiao Lu MD, Kunhan Ni MD, Yixuan Huang MD, Longlin Jiang MD, Kangning Wang MD, PhD, Haojun Li MD, Qiang Fang MD, PhD, Wenguang **ao MD, Yongtao Han MD, Xuefeng Leng MD, PhD & Lin Peng MD

Authors
  1. Kexun Li MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. **n Nie MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Changding Li MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Wenwu He MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Chenghao Wang MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Kunyi Du MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Kunzhi Li MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Kun Liu MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Zhiyu Li MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Simiao Lu MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. Kunhan Ni MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  12. Yixuan Huang MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  13. Longlin Jiang MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  14. Kangning Wang MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  15. Haojun Li MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  16. Qiang Fang MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  17. Wenguang **ao MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  18. Yongtao Han MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  19. Xuefeng Leng MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  20. Lin Peng MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

Study concept and design; acquisition, analysis, or interpretation of data; revising the article critically for important intellectual content; final approval of the version to be published: All authors. Drafting of the article: KL. Statistical analysis: XN. Obtained funding: LP. Administrative, technical, or material support: XL, LP. Study supervision: YH, LP, KL, XN, and CL had full access to all the data in the study and take responsibility for the integrity of the data and the accuracy of the data analysis. KL, XN, and CL have contributed equally to this work.

Corresponding authors

Correspondence to Xuefeng Leng MD, PhD or Lin Peng MD.

Ethics declarations

Disclosure

Kexun Li, **n Nie, Changding Li, Wenwu He, Chenghao Wang, Kunyi Du, Kunzhi Li, Kun Liu, Zhiyu Li, Simiao Lu, Kunhan Ni, Yixuan Huang, Longlin Jiang, Kangning Wang, Haojun Li, Qiang Fang, Wenguang **ao, Yongtao Han, Xuefeng Leng, and Lin Peng declare they have no known competing financial interests or personal relationships that could have influenced the work reported in this paper.

Ethical Approval

This study was approved by the EC for Medical Research and New Medical Technology of Sichuan Cancer Hospital (SCCHEC-02-2022-050).

Informed Consent

The data are anonymous and the requirement for informed consent was therefore waived.

Meeting presentations

Partial preliminary results of this article were reported in the Featured Abstracts presented by the first author of this article at the 18th World Congress for Esophageal Diseases (ISDE 2022), which was held virtually from 26 to 29 September 2022. Partial preliminary results of this article were reported in the Excellent Abstracts presented to the Chinese Conference on Oncology (CCO), which was held virtually from 17 to 20 November 2022.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Li, K., Nie, X., Li, C. et al. Map** of Lymph Node Metastasis and Efficacy Index in Thoracic Esophageal Squamous Cell Carcinoma: A Large-Scale Retrospective Analysis. Ann Surg Oncol 30, 5856–5865 (2023). https://doi.org/10.1245/s10434-023-13655-5

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1245/s10434-023-13655-5

Search

Navigation